Professor Kim Hemsley,
Head of Childhood Dementia Research Group
Flinders University
ADELAIDE, SOUTH AUSTRALIA
-
Professor Alex Fornito
PROFESSOR ALEX FORNITO
HEAD OF THE BRAIN MAPPING AND MODELLING RESEARCH PROGRAM
TURNER INSTITUTE FOR BRAIN AND MENTAL HEALTH, MONASH UNIVERSITY
VICTORIA, AUSTRALIA -
Joanne Chio
ICON CANCER CENTRE – SINGAPORE
SINGAPORE -
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
